Pulse Biosciences, Inc.
PLSE
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company wasā¦ read more
Healthcare
Medical Instruments & Supplies
10 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$35.13
Price+0.26%
$0.09
1Y
Price
Market Cap
$2.431b
Mid
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-4712.0%
EBITDA Margin-4633.7%
Net Profit Margin-3647.9%
Free Cash Flow Margin-4712.0%
EBITDA Margin-4633.7%
Net Profit Margin-3647.9%
Free Cash Flow MarginRevenue
$751k
+114.6%
1y CAGR+38.2%
3y CAGR+3.6%
5y CAGREarnings
-$74.567m
-2.4%
1y CAGR-21.7%
3y CAGR-9.3%
5y CAGREPS
-$1.09
-0.9%
1y CAGR-7.6%
3y CAGR+6.5%
5y CAGRBook Value
$66.298m
$81.622m
Assets$15.324m
Liabilities$7.155m
DebtDebt to Assets
8.8%
-0.1x
Debt to EBITDAFree Cash Flow
-$55.499m
-1.9%
1y CAGR-20.4%
3y CAGR-7.8%
5y CAGRNo items found.
Press Releases
Statements and updates from the company